期刊
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
卷 58, 期 1, 页码 27-36出版社
SPRINGER BASEL AG
DOI: 10.1007/s00005-009-0058-1
关键词
Rheumatoid arthritis; Immunotherapy; Inflammatory cytokines; Autoreactive T cells; Regulatory T cells; Th17 cells
类别
资金
- Shanghai commission of Science and Technology (Shanghai Nature Science Foundation [07ZR14066, 08ZR1416100]
- NSFC [30972743]
- Shanghai Board of Health Foundation [2007126]
- Shanghai Institute of Immunology [08-A08]
- Shanghai Municipal Education Commission [09YZ104, J50207]
Rheumatoid arthritis is a chronic disorder for which there is no known cure. Concentrating on specific elements of the abnormal immune response that characterizes the disease, scientists are reaching into biotechnology's bag of tricks to develop immunotherapeutic techniques. This paper will present some advances in the immunotherapy of rheumatoid arthritis targeting inflammatory cytokines and autoreactive T cells.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据
分享论文
